Your Notifications
All done, no notifications

Malignant Mesothelioma Treatment Cost in United Arab Emirates

USD 3000 - USD 40000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

25
Days in Hospital
4-8 hrs
Procedure Time
12%
Success Rate
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 3000 - USD 40000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator

International Quality. Affordable Care.

How Much Does Malignant Mesothelioma Treatment Cost in United Arab Emirates?

The cost of malignant mesothelioma treatment in the United Arab Emirates ranges between USD 11000 - USD 12000.

The total treatment cost may vary based on whether the patient requires surgery, chemotherapy, radiation therapy, immunotherapy, or a combination of these treatments. Additional factors such as advanced treatment technologies, hospitalisation, rehabilitation, and follow-up care can also influence the overall expense.

Factors Influencing the Cost of Malignant Mesothelioma Treatment

  • Treatment Procedure: Overall expenses depend on whether the treatment involves surgery, chemotherapy, radiation therapy, immunotherapy, or a combination of different therapies. Some highly sophisticated procedures like extrapleural pneumonectomy (EPP) and pleurectomy/decortication (P/D) might be more expensive.
  • Extent of Disease: Early-stage mesothelioma might require less complicated treatment, while later stages might involve multiple methods and take longer.
  • Hospital Location: International hospitals and cancer treatment centres in the capital can be much more expensive due to their modern equipment and wide range of services.
  • Professional Experience: A large number of specialists and highly skilled oncologists dealing with mesothelioma patients can charge more for their services.
  • Pre-treatment Examination: Diagnostic procedures should be done before treatment, such as CT, PET-CT and MRI scans, biopsy, blood tests, function tests, as well as staging exams.
  • Innovative Treatment: Services such as robotic surgery and modern radiation technology, as well as prominent chemotherapy regimens used to treat mesothelioma, can increase treatment costs.
  • Hospitalisation and Post-treatment Care: The final treatment cost includes expenses for hospitalisation, medication, rehab, and aftercare.

What's included in your Malignant Mesothelioma Treatment quote?

Comprehensive oncology evaluation
Specialist consultation, pathology review, staging investigations, and treatment planning
Multidisciplinary oncology team
Thoracic surgeon, medical oncologist, radiation oncologist, and pulmonologist
Hospital stay + ICU as needed
Inpatient treatment with intensive care support when medically necessary
Country stay monitoring
Clinical review, imaging, laboratory tests, and treatment response assessment
Visa & medical-visa invite letter
Airport pickup & transfers

Cost of Malignant Mesothelioma Treatment in Major Cities of United Arab Emirates

CityCost (USD)
Abu Dhabi $11,000 – $12,000 Explore More
Dubai $11,000 – $12,000 Explore More
Sharjah $11,000 – $12,000 Explore More

Malignant Mesothelioma Treatment - United Arab Emirates Vs the World

$4k - $4k
$4k - $8k
$8k - $20k
$10k - $50k
$11k - $12k
$15k - $35k
$25k - $60k
$28k - $65k
$30k - $60k
$40k - $70k
$45k - $60k
Dr. Shagufta Parveen
Author

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

View More
Dr Prateek Varshney
Reviewer

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

15 min
Average response time

Serving Patients Worldwide in Multiple Languages.

Mesothelioma is a cancer that starts as an overgrowth of mesothelium cells. A thin layer of tissue called the mesothelium covers many of the internal organs.

It occurs most often in the tissue around the lungs, which is referred to as pleural mesothelioma. Mesothelioma can also occur in the tissues around the testicles, heart, and abdomen.

Malignant mesothelioma, or simply mesothelioma, is a fast-growing cancer that is terminal. Mesothelioma has treatments. Yet, there is no treatment for mesothelioma in most instances.

The objectives of treating malignant mesothelioma are to reduce or eradicate the malignancy, alleviate symptoms like dyspnea and chest discomfort, and enhance survival and quality of life. Since it's an aggressive cancer often linked to asbestos exposure, early and effective treatment is essential to slow its progression and extend life expectancy.

See a doctor if you suffer from chronic symptoms including chest or abdominal pain, shortness of breath, unexpected weight loss, or fluid accumulation around the lungs or abdomen, especially if you have been exposed to asbestos.

Diagnostic testing is necessary before beginning treatment for malignant mesothelioma to determine the stage and kind of malignancy. Patients consult with specialists to determine the optimal course of treatment. Maintaining general health and making support arrangements before starting therapy is also critical.

In order to eradicate or manage cancer, malignant mesothelioma treatment frequently involves surgery, chemotherapy, and radiation. To strengthen the immune system, immunotherapy may be added for more advanced stages. Palliative care enhances life quality by reducing symptoms.

Surgery for malignant mesothelioma can take 4-6 hours, and patients may need to stay in the hospital for up to 2 weeks. Chemotherapy usually spans 3 to 6 months in cycles, and radiation may last several weeks. Depending on each patient's response, the entire course of treatment and recovery may take several months.

  • Infection or
  • Bleeding after surgery
  • Fatigue, nausea, and hair loss from chemotherapy
  • Lung issues, such as difficulty breathing
  • Neurological side effects
  • Pulmonary fibrosis
  • Fluid buildup in the chest or abdomen post-surgery

Treatment for malignant mesothelioma can increase survival rates, improve quality of life, and shrink tumour size. Pain and dyspnea are among the symptoms that palliative care helps control.

Post-operative recovery from malignant mesothelioma treatment includes monitoring for complications, managing pain and breathing difficulties, and following up with physical therapy to regain strength.

Unfortunately, the success rate of malignant mesothelioma treatment is low. The 5-year survival rate is generally around 12%.

12%

Five-year survival rate

25-10 days

Typical hospital stay after major surgery (if performed)

2 Months

Initial recovery after surgery; recovery varies based on treatment type
Explore Hospitals ( 10 )

Dubai, United Arab Emirates

4.5 - 1 review · 100+ Beds · 165+ Procedures
JCI
Starting
USD 3000

Dubai, United Arab Emirates

1.0 - 1 review · 114+ Beds · 208+ Procedures
JCI NABH NABL
Starting
USD 5000

Sharjah, United Arab Emirates

3.3 - 5 reviews · 137+ Beds · 204+ Procedures
JCI
Starting
USD 10000

Dubai, United Arab Emirates

200+ Beds · 174+ Procedures
JCI
Starting
USD 8000

Abu Dhabi, United Arab Emirates

500+ Beds · 223+ Procedures
JCI
Starting
USD 26000

Sharjah, United Arab Emirates

75+ Beds · 247+ Procedures
JCI
Starting
USD 5000

Dubai, United Arab Emirates

220+ Beds · 215+ Procedures
Starting
USD 6000

Dubai, United Arab Emirates

143+ Procedures
JCI

Sharjah, United Arab Emirates

0.5 - 1 review · 185+ Beds · 287+ Procedures
JCI
Starting
USD 10000

Abu Dhabi, United Arab Emirates

200+ Beds · 147+ Procedures
JCI
Starting
USD 20000

Get Your Malignant Mesothelioma Treatment
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

Free Consultation No Obligation Personalized Treatment Plan Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Process Involved for Malignant Mesothelioma Treatment in United Arab Emirates

Malignant Mesothelioma treatment is generally determined based on the disease's stage. Below is an outline of the stages and their corresponding treatment approaches:

  • Stage I (Localized): At this stage, the cancer remains confined to the mesothelial lining. The primary treatment often involves surgical removal of the tumor, which may be supplemented by chemotherapy or radiation therapy to eliminate residual cancer cells.
  • Stage II (Nearby Spread): The cancer extends to adjacent organs, such as the diaphragm or lungs. Treatment options might include surgery, along with chemotherapy and radiation therapy, to manage the progression.
  • Stage III (Lymph Node Involvement): The cancer reaches lymph nodes and nearby tissues. Efforts are focused on controlling the disease, using a combination of chemotherapy, radiation therapy, and possibly palliative surgery to alleviate symptoms.
  • Stage IV (Distant Spread): At this advanced stage, the cancer spreads to distant organs and tissues. Treatments are typically palliative, aimed at improving the quality of life, and may include chemotherapy, targeted therapy, and supportive care.

Malignant Mesothelioma

Eligibility for treatment of malignant mesothelioma depends on several factors, including the patient's overall health, the stage and type of mesothelioma, and prior treatments. Here are some general criteria:

  • Diagnosis Confirmation: The patient must have a confirmed diagnosis of mesothelioma, typically through biopsy and imaging studies.
  • Type and Stage: The specific type (e.g., pleural or peritoneal) and stage of mesothelioma play a crucial role in determining treatment options.
  • Performance Status: The patient's general health and ability to perform daily activities are considered.
  • Treatment History: Previous treatments, such as chemotherapy or immunotherapy, may influence eligibility for further interventions.
  • Surgical Candidacy: For some patients, surgery may be an option if the disease is localized and the patient is healthy enough to undergo the procedure.

In addition to the primary treatments for Malignant Mesothelioma (surgery, chemotherapy, radiation therapy, and targeted therapy), there are several associated or complementary treatments that can support patients:

  1. Immunotherapy: This treatment boosts the body's immune system to fight cancer cells. Drugs like nivolumab and ipilimumab are examples used in mesothelioma treatment.
  2. Palliative Care: Focused on improving quality of life, palliative care includes pain management, respiratory therapy, and emotional support.
  3. Clinical Trials: Patients may participate in trials exploring new drugs, therapies, or combinations of treatments.
  4. Supportive Therapies: These include nutritional counseling, physical therapy, and psychological support to help manage symptoms and side effects.

Malignant Mesothelioma treatment offers various benefits, tailored to the disease stage and type of therapy. Key advantages include:

  • Prolonged Survival: Surgical procedures, chemotherapy, and radiation therapy can extend patients' life expectancy by effectively controlling the disease's spread.
  • Symptom Relief: Palliative care options, such as pain management and respiratory therapy, greatly enhance quality of life by addressing symptoms like chest pain, breathlessness, and fatigue.
  • Enhanced Quality of Life: Supportive treatments, including nutritional guidance and psychological care, help patients maintain both physical and emotional well-being throughout the treatment process.
  • Possibility of Remission: In early stages, comprehensive treatment plans involving surgery alongside chemotherapy or radiation therapy may result in remission or long-term disease control.
  • Access to Advanced Therapies: Enrollment in clinical trials enables patients to benefit from cutting-edge innovations such as immunotherapy and targeted therapy
  • Medical Oncologists
  • Radiation Oncologists
  • Pulmonologists
  • Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
  • Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
  • Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
  • Choose your preferred option: Choose the therapy option that best suits you.
  • Seamless Organization: We will manage all the details, including visas, flights, accommodations, and transfers, for a stress-free journey.
Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Silim Shabani
Silim Shabani
Patient Testimonial: Silim Shabani for Ovarian Cancer Treatment in Turkey

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for…

Frequently Asked Questions

The cost of Malignant Mesothelioma Treatment in United Arab Emirates may vary depending on the type and stage of mesothelioma, tumour location (pleural, peritoneal, or other forms), treatment approach, diagnostic investigations, hospital charges, specialist consultation fees, surgery, chemotherapy, immunotherapy, radiation therapy, supportive care, and duration of treatment. The overall cost may include consultations, imaging studies, biopsy, pathology, surgery when indicated, systemic therapy, hospitalisation, rehabilitation, and long-term follow-up care.MediGence can help international patients explore suitable cancer centres and obtain an estimated treatment plan based on the patient's diagnosis, disease stage, and clinical requirements.

The best hospitals in United Arab Emirates for Malignant Mesothelioma Treatment are those with experienced thoracic surgeons, surgical oncologists, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, and multidisciplinary cancer teams. Patients should consider hospitals with specialised thoracic oncology programmes, advanced diagnostic imaging, dedicated cancer centres, intensive care support, and comprehensive supportive and palliative care services.

Patients should choose a thoracic oncologist or thoracic surgeon experienced in the diagnosis and management of malignant mesothelioma. Important factors include expertise in cytoreductive surgery, pleurectomy/decortication, extrapleural pneumonectomy when appropriate, chemotherapy, immunotherapy, and multidisciplinary treatment planning.The treating team should evaluate biopsy findings, histological subtype, tumour stage, imaging studies, pulmonary function, overall health, and treatment goals before recommending an individualised treatment plan.

The success rate of Malignant Mesothelioma Treatment is approximately 12%, depending on the stage of the disease, histological subtype, tumour location, response to treatment, overall health, and the treatment approach used. Early diagnosis and management at experienced multidisciplinary cancer centres may improve outcomes and quality of life.

Hospitals in United Arab Emirates may use high-resolution CT scans, PET-CT imaging, MRI, thoracoscopy, image-guided biopsy, molecular pathology, pulmonary function testing, minimally invasive thoracic surgery, Video-Assisted Thoracoscopic Surgery (VATS), robotic-assisted surgery in selected cases, intensity-modulated radiation therapy (IMRT), chemotherapy, immunotherapy, targeted therapy where appropriate, and comprehensive supportive oncology care.Treatment is individualised and may involve surgery, systemic therapy, radiation therapy, or multimodal treatment depending on the stage and extent of the disease.

Possible risks and complications may include:
  • Bleeding
  • Surgical site infection
  • Respiratory complications
  • Air leak following thoracic surgery
  • Pneumonia
  • Pleural effusion
  • Fatigue
  • Nausea and vomiting related to chemotherapy
  • Low blood cell counts and increased infection risk
  • Side effects related to immunotherapy
  • Pain
  • Blood clots
  • Disease recurrence or progression
  • Rare complications related to anaesthesia or major thoracic surgery
  • The treating oncology team will explain the potential risks based on the patient's diagnosis, treatment plan, and overall health.

    Patients should share all relevant medical records with the treating oncology team before travelling. These may include CT, PET-CT, or MRI reports, biopsy and pathology findings, thoracoscopy reports, pulmonary function tests, blood test results, previous treatment records, medication history, and allergy information.Patients should also discuss the expected treatment duration, surgical options if applicable, accommodation requirements, nutritional support, rehabilitation, caregiver arrangements, and follow-up plan before making travel arrangements.

    Yes. International patients can arrange an online consultation with a thoracic oncologist, thoracic surgeon, or medical oncologist before travelling to United Arab Emirates. The specialist may review the patient's imaging studies, pathology reports, pulmonary function tests, previous treatments, and overall clinical condition to recommend an appropriate treatment plan.MediGence can help coordinate online consultations and facilitate the secure sharing of relevant medical records with suitable specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • CT, PET-CT, and MRI reports
  • Biopsy and pathology reports
  • Thoracoscopy reports, if available
  • Pulmonary function test results
  • Blood test results
  • Previous oncology consultation records
  • Previous surgery, chemotherapy, immunotherapy, or radiation therapy records
  • Current prescriptions and medication details
  • Allergy and complete medical history
  • The required stay in United Arab Emirates depends on the stage of the disease, treatment plan, and postoperative or systemic therapy requirements. Surgery may require hospitalisation followed by recovery, while chemotherapy, immunotherapy, or radiation therapy may require several weeks of treatment.Patients may need to remain in United Arab Emirates until the planned treatment cycle is completed, postoperative recovery is satisfactory when applicable, treatment-related side effects are well managed, and the treating team confirms that the patient is fit to travel.

    Recovery varies depending on the treatment received and the patient's overall health. Recovery following major thoracic surgery may take several weeks to months, while patients receiving chemotherapy or immunotherapy may require ongoing monitoring throughout treatment.Long-term follow-up includes imaging studies, pulmonary assessment, symptom management, rehabilitation, and regular oncology consultations to monitor treatment response and detect recurrence or disease progression.

    If complications occur, patients should contact the treating oncology team or seek immediate medical attention. Prompt evaluation may be required for severe shortness of breath, persistent fever, excessive bleeding, worsening chest pain, wound infection, uncontrolled nausea or vomiting, severe fatigue, signs of blood clots, or symptoms suggestive of disease progression.Patients should receive detailed discharge instructions, medication guidance, emergency contact information, rehabilitation recommendations, and a structured oncology follow-up plan before returning home.

    International patients can submit their medical records, pathology reports, and imaging studies through the MediGence website. Following an initial review, the MediGence care team can help patients explore suitable cancer hospitals and experienced thoracic oncology specialists, coordinate consultations, and support treatment planning and medical travel arrangements.The final treatment recommendation is made by the treating multidisciplinary oncology team after a comprehensive clinical evaluation.

    International patients may choose United Arab Emirates for access to experienced thoracic oncology specialists, multidisciplinary cancer centres, advanced diagnostic imaging, modern surgical techniques, comprehensive systemic therapy options, specialised respiratory care, and supportive oncology services.The destination should be evaluated based on physician expertise, hospital accreditation, patient safety standards, availability of advanced cancer therapies, and experience in managing complex thoracic malignancies such as malignant mesothelioma.

    Treatment options depend on the type, stage, tumour location, overall health, and treatment goals. Options may include:
  • Pleurectomy/Decortication (P/D)
  • Extrapleural Pneumonectomy (EPP) for selected patients
  • Cytoreductive surgery for selected peritoneal mesothelioma
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for selected peritoneal cases
  • Chemotherapy
  • Immunotherapy
  • Radiation therapy
  • Palliative procedures such as pleural drainage or pleurodesis
  • Supportive and palliative care
  • Long-term oncology follow-up and surveillance
  • The treating multidisciplinary oncology team will recommend the most appropriate treatment plan after evaluating the patient's diagnosis and overall clinical condition.

    International patients may choose United Arab Emirates for access to specialised thoracic oncology centres, experienced multidisciplinary cancer teams, advanced surgical expertise, modern immunotherapy and chemotherapy options, comprehensive supportive care, and personalised treatment planning.MediGence can assist patients with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient's diagnosis, disease stage, clinical requirements, treatment goals, and the hospital's expertise in Malignant Mesothelioma Treatment.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan